Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer

被引：0
|
作者：
Shinkichi Takamori
Mototsugu Shimokawa
Taichi Matsubara
Naoki Haratake
Ryo Toyozawa
Naoko Miura
Masafumi Yamaguchi
Takashi Seto
Tetsuzo Tagawa
Tatsuro Okamoto
Mitsuhiro Takenoyama
Yoshihiko Maehara
Masaki Mori
机构：
[1] National Hospital Organization Kyushu Cancer Center,Department of Thoracic Oncology
[2] Yamaguchi University Graduate School of Medicine,Department of Biostatistics
[3] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
[4] Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers,Department of Surgery
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
Non-small cell lung cancer; Smoking; Surgery; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：685 / 694
页数：9
相关论文
共 50 条
  • [21] Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer
    Hanagiri, Takeshi
    Sugio, Kenji
    Mizukami, Makiko
    Ichiki, Yoshinobu
    Sugaya, Masakazu
    Yasuda, Manabu
    Takenoyama, Mitsuhiro
    Yasumoto, Kosei
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (10) : 1127 - 1132
  • [22] Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer
    Xie, Mian
    Zhang, Li
    He, Chao-Sheng
    Hou, Jin-Hui
    Lin, Su-Xia
    Hu, Zhi-Huang
    Xu, Fei
    Zhao, Hong-Yun
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (05) : 799 - 807
  • [23] IMMUNE MARKERS IN SURGICALLY RESECTED EARLY STAGE NON-SMALL CELL LUNG CANCER PATIENTS
    Uysal, Pelin
    Kilic, Burcu
    Demirkaya, Ahmet
    Afsar, Cigdem Usul
    Karaca, Feryal
    ACTA MEDICA MEDITERRANEA, 2019, 35 (01): : 65 - 69
  • [24] The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer-Differences between adenocarcinoma and squamous cell carcinoma
    Okamoto, Tatsuro
    Suzuki, Yuzo
    Fujishita, Takatoshi
    Kitahara, Hirokazu
    Shimamatsu, Shinichiro
    Kohno, Mikihiro
    Morodomi, Yosuke
    Kawano, Daigo
    Maehara, Yoshihiko
    LUNG CANCER, 2014, 85 (02) : 125 - 130
  • [25] C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
    Tsakonas, G.
    Hirsch, F. R.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2124 - S2125
  • [26] Prognostic impact of serum transthyretin in patients with non-small cell lung cancer
    Shimura, Tatsuo
    Shibata, Masahiko
    Inoue, Takuya
    Owada-Ozaki, Yuki
    Yamaura, Takumi
    Muto, Satoshi
    Hasegawa, Takeo
    Shio, Yutaka
    Suzuki, Hiroyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (06) : 597 - 604
  • [27] The association of topoisomerase 2α expression with prognosis in surgically resected non-small cell lung cancer (NSCLC) patients
    Erguden, Hulya Celenk
    Koksal, Deniz
    Demirag, Funda
    Bayiz, Hulya
    Mutluay, Neslihan
    Berktas, Bahadir
    Berkoglu, Mine
    JOURNAL OF THORACIC DISEASE, 2012, 4 (04) : 352 - 357
  • [28] Clinical Impact of Histologic Type in Patients with Surgically Resected Stage II and III Non-small Cell Lung Cancer
    Kim, H. R.
    Yun, J. K.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S294 - S295
  • [29] The value of tumor volume in surgically resected non-small cell lung cancer
    Iwasaki, A
    Shirakusa, T
    Enatsu, S
    Maekawa, S
    Hamada, T
    Hamasaki, M
    THORACIC AND CARDIOVASCULAR SURGEON, 2006, 54 (02) : 112 - 116
  • [30] Clinical Implications of Transbronchial Biopsy for Surgically-resected Non-small Cell Lung Cancer
    Yasukawa, Motoaki
    Sawabata, Noriyoshi
    Kawaguchi, Takeshi
    Kawai, Norikazu
    Taniguchi, Shigeki
    IN VIVO, 2018, 32 (03): : 691 - 698
12345